Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines
Status:
Completed
Trial end date:
2012-02-28
Target enrollment:
Participant gender:
Summary
This study evaluated the safety and efficacy of botulinum toxin Type A compared to placebo
for the treatment of forehead lines (facial rhytides) when also administered to frown lines
(glabellar rhytides).
Phase:
N/A
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA